Moderna Inc's coronavirus vaccine on Friday became the second to receive emergency use authorization (EUA) from the U.S. Food and Drug Administration, welcome news to a nation with a staggering COVID-19 death toll of over 307,000 lives lost.
Brazil’s health regulator Anvisa said on Wednesday it was open to approving COVID-19 vaccines for emergency use and outlined the requirements for companies looking to do so.